Skip to main content

Real-World Data on the Intravascular Microaxial Left Ventricular Flow Pump (Impella) in High-Risk Patients.

Publication ,  Journal Article
Rao, SV
Published in: Korean Circ J
June 2021

Mechanical circulatory support (MCS) devices maintain or improve hemodynamic profiles in patients at risk for hemodynamic deterioration during percutaneous coronary intervention (PCI) or those in cardiogenic shock. Clinical trials of MCS have been difficult to complete due to challenges with equipoise; however, there are several "real-world" comparative effectiveness analyses of outcomes of patients undergoing high-risk PCI or cardiogenic shock with different MCS. This review summarizes the real-world data on Impella and intra-aortic balloon pump, 2 of the most commonly used MCS, and provides insight into the limitations of such data and challenges to completing clinical trials.

Duke Scholars

Published In

Korean Circ J

DOI

ISSN

1738-5520

Publication Date

June 2021

Volume

51

Issue

6

Start / End Page

487 / 494

Location

Korea (South)
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rao, S. V. (2021). Real-World Data on the Intravascular Microaxial Left Ventricular Flow Pump (Impella) in High-Risk Patients. Korean Circ J, 51(6), 487–494. https://doi.org/10.4070/kcj.2021.0102
Rao, Sunil V. “Real-World Data on the Intravascular Microaxial Left Ventricular Flow Pump (Impella) in High-Risk Patients.Korean Circ J 51, no. 6 (June 2021): 487–94. https://doi.org/10.4070/kcj.2021.0102.
Rao, Sunil V. “Real-World Data on the Intravascular Microaxial Left Ventricular Flow Pump (Impella) in High-Risk Patients.Korean Circ J, vol. 51, no. 6, June 2021, pp. 487–94. Pubmed, doi:10.4070/kcj.2021.0102.

Published In

Korean Circ J

DOI

ISSN

1738-5520

Publication Date

June 2021

Volume

51

Issue

6

Start / End Page

487 / 494

Location

Korea (South)